Neutralizing Monoclonal Antibodies in COVID-19 and Infusion Center Operations: Experiences and Insights Regarding Your Pressing Questions

register for 1 of 6 activities below

OVERVIEW

This Peer-to-Peer Clinical Connection series comprises 6 virtual live activities with interaction among expert clinicians, a facilitator, and an intimate audience of 8 to 12 invited clinicians, with simultaneous onscreen visibility available for all learners. Small-group interaction allows a direct connection with the expert as well as fellow learners for an intimate, in-depth clinical conversation that mirrors the networking and collaborative experience typically found in live local meetings. Video is encouraged by all participants.   

Each hour-long session will be led by a team of experts, allowing each session discussion to be unique to the presenters and participants.  

Faculty will review the role of monoclonal antibodies (mAbs) in the immune response for COVID-19; highlight the role of mAbs  in the treatment of COVID-19; discuss the latest updates on mAb therapies for COVID-19; and strategies for optimizing infusion center operations. Register for 1 of the 6 events!  

WEDNESDAY, JUNE 23, 2021
7:00 - 8:00 PM EDT

TUESDAY, JUNE 29, 2021
1:00 - 2:00 PM EDT

FACULTY

MONDAY, JUNE 28, 2021
7:00 - 8:00 PM EDT

WEDNESDAY, JUNE 30, 2021
1:00 - 2:00 PM EDT

FACULTY

MONDAY, JUNE 28, 2021
3:00 - 4:00 PM EDT

WEDNESDAY, JUNE 30, 2021
7:00 - 8:00 PM EDT

FACULTY

AGENDA

Introduction (5 min.)

Updates on Clinical Trial Data and Real-World Use of mAbs in the Treatment of COVID-19 (10 min.)

Case-Based Discussion (10 min.)

Infusion Site Center Learnings (5-10 min.)

Peer Discussion and Q&A (20 min.)

Concluding Remarks (5 min.)

 

TARGET AUDIENCE

This activity is intended for physicians, nurses, nurse practitioners (NPs), physician assistants (PAs) involved in the care of high-risk patients with mild to moderate COVID-19 disease who are interested in setting up an infusion center for mAbs.

GOAL STATEMENT

The goal of this activity is to provide physicians, nurses, and other clinicians with expert guidance on best practices based on the latest clinical and real-world use of Emergency Use Authorization (EUA) neutralizing antibody (NAb) infusions and to foster their appropriate use in the treatment of patients with mild to moderate COVID-19.

LEARNING OBJECTIVES

Upon completion of this activity, participants will: Have increased knowledge regarding the[LIST] [ITEM]Identification of patients who are candidates for NAbs[/LIST]Have greater competence related to [LIST] [ITEM]Appropriate follow-up for patients after NAb infusion[ITEM]Monitoring patients for reactions during NAb infusion[/LIST]Demonstrate greater confidence in their ability to [LIST] [ITEM]Collaborate with the interprofessional team to run a successful NAb infusion center[/LIST]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]

[BOLD]For Physicians[/BOLD] Medscape, LLC designates this live activity for a maximum of 1.0 [BOLD] [italic]AMA PRA Category 1 Credit(s)™[/italic] [/BOLD]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [BOLD]For Nurses[/BOLD] Awarded 1.0 contact hour(s) of nursing continuing professional development for RNs and APNs